What is the recommended treatment for a partner with Chlamydia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Partners with Chlamydia

The recommended first-line treatment for a partner with chlamydia is doxycycline 100 mg orally twice daily for 7 days, which has superior efficacy (95.5% for urogenital infections and 96.9% for rectal infections) compared to alternative regimens. 1

Treatment Options

First-Line Treatment

  • Doxycycline: 100 mg orally twice daily for 7 days 1, 2
    • Highest efficacy for both urogenital (95.5%) and rectal (96.9%) infections 1
    • FDA-approved specifically for uncomplicated urethral, endocervical, or rectal infections caused by Chlamydia trachomatis 2

Alternative Treatment Options

  • Azithromycin: 1 g orally in a single dose 1

    • Efficacy: 92% for urogenital infections, but only 76.4% for rectal infections 1
    • Preferred when adherence is a concern (directly observed therapy possible) 1
    • Lower efficacy compared to doxycycline, especially for rectal infections 3
  • Erythromycin options (for patients who cannot take doxycycline):

    • Erythromycin base 500 mg orally four times daily for 7 days 1, 4
    • Erythromycin base 250 mg orally four times daily for 14 days 1
    • Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 1
    • Erythromycin ethylsuccinate 400 mg orally four times daily for 14 days 1

Partner Management Guidelines

  • All sexual partners from the preceding 60 days should be evaluated, tested, and treated 1
  • If the last sexual contact was more than 60 days before diagnosis, the most recent partner should still be treated 1
  • Partners should abstain from sexual intercourse until:
    • 7 days after completing single-dose therapy, OR
    • Until completion of a 7-day regimen 1

Special Considerations

Co-infection with Gonorrhea

  • Consider dual therapy with ceftriaxone 125 mg IM in a single dose PLUS azithromycin 1 g orally in a single dose OR doxycycline 100 mg orally twice daily for 7 days 1
  • This approach addresses increasing resistance patterns and treats potential co-infections 1

Pregnancy

  • Doxycycline is contraindicated during pregnancy 1
  • Azithromycin or erythromycin should be used instead 1, 4

Maximizing Treatment Success

  • Medications should be dispensed on-site when possible 1
  • First dose should be directly observed to improve compliance 1
  • Test of cure is generally not needed after completing treatment with doxycycline or azithromycin unless symptoms persist 1
  • Test of cure should be considered 3 weeks after completion of treatment with erythromycin 1

Follow-up Recommendations

  • Retesting is recommended approximately 3 months after treatment due to high risk of reinfection (up to 39% in some studies) 1
  • Consistent and correct condom use is recommended to reduce reinfection risk 1

Common Pitfalls to Avoid

  • Undertreating rectal infections: Azithromycin has significantly lower efficacy for rectal chlamydia (76.4%) compared to doxycycline (96.9%) 1, 3
  • Failing to treat partners: High reinfection rates make partner treatment essential 1
  • Inadequate follow-up: Retesting at 3 months is crucial due to high reinfection rates 1
  • Missing co-infections: Patients with chlamydia often have concurrent gonorrhea requiring dual therapy 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.